Lidocaine Hci Injection
Product Images NDC 51662-1382

10 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure 2023)

Structure (Structure 2023)
Chemical structure diagram of lidocaine hydrochloride showing the molecular arrangement of atoms in the compound.*
FDA Label Image

Precautions (Precautions 2023)

Precautions (Precautions 2023)
A data table categorizing drug classes and providing examples for each. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, listing respective example drugs under each category.*
FDA Label Image

Dosage (Dosage 2023)

Dosage (Dosage 2023)
A data table titled Lidocaine Hydrochloride Injection, USP showing concentrations (%), volumes (mL), and total dose ranges (mg) for various procedures including infiltration, peripheral nerve blocks, sympathetic nerve blocks, central neural blocks (epidural, caudal), and specific indications such as analgesia and anesthesia in different anatomical areas.*
FDA Label Image

How Supplied (How Supplied 2023)

How Supplied (How Supplied 2023)
Instructional diagram showing three steps for preparing an injector: 1) Removing protective caps, 2) threading a vial into the injector by turning 3 half turns or until the stopper is pierced by a metal cannula, with a warning not to push the vial into the injector to avoid misalignment, and 3) removing the cover to expel air. Each step is accompanied by a simple line drawing of hands performing the actions.*
FDA Label Image

Serialized Label (Serialized Labeling)

Serialized Label (Serialized Labeling)
LIDOCAINE HCI injection label displaying serialization barcodes and identifiers, including product codes and expiration date. The label states distribution by HF Acquisition Co, LLC, Mukilteo, WA. It indicates the product is for prescription use only (RX ONLY).*
FDA Label Image

Rfid Label (51662 1382 1 Rfid Label)

Rfid Label (51662 1382 1 Rfid Label)
A barcode label for LIDOCAINE HCI injection displaying numeric and alphanumeric codes including identifiers such as (01) and (21) series numbers. The text advises to see the manufacturer's insert and states distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. A Data Matrix 2D barcode and the word RXONLY are visible vertically on the right side of the label.*
FDA Label Image

Carton-box Labeling (5166201382 1 Carton Box Label)

Carton-box Labeling (5166201382 1 Carton Box Label)
Packaging label for LIDOCAINE HCI Injection, USP 2%, containing 100 mg per 5 mL (20 mg/mL) in a prefilled syringe. The label highlights its use for intravenous injection for infiltration and nerve block. The labeler is HF Acquisition Co LLC, DBA HealthFirst. The label includes instructions for use and product information in red and white colors.*
FDA Label Image

Pouch Label (51662 1382 2)

Pouch Label (51662 1382 2)
Text panel for Lidocaine HCl Injection, USP 2% (20 mg/mL), 100 mg per 5 mL, Luer-Jet Syringe. Includes NDC number 51662-1382-2, lot number, and expiration date. Provides intravenous injection usage instructions, components, storage conditions (20 to 25°C), and dispensing guidance. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA. Contains a QR code at the bottom right.*
FDA Label Image

Case Label (51662 1382 3)

Case Label (51662 1382 3)
Label for Lidocaine HCl Injection, USP 2%, 100 mg per 5 mL vial, supplied as a case of 10. The product is an intravenous injection for infiltration and nerve block, containing lidocaine hydrochloride 20 mg per mL. Manufactured by HF Acquisition Co., LLC, located in Mukilteo, WA. The label also includes NDC 51662-1382-3, lot number, expiration date, storage instructions, and directions to consult the package insert for dosage.*
FDA Label Image

Rfid Label (51662 1382 3 Case Rfid)

Rfid Label (51662 1382 3 Case Rfid)
Label for LIDOCAINE HCI 20 mg/mL injection, distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA 98275. The label includes a barcode, numeric identifiers, and directs to see the manufacturer's insert for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.